Welcome and Introductions (5 mins)
Primary Care Considerations for Functional Bowel Disorder (25 mins)
- Disease Burden; Effective Patient–Provider Communication
- Making the Diagnosis and Next Steps
- Treatment Approaches, Including Diet, OTCs, and Prescription Agents
Question and Answer Session (15 mins)
Lin Chang, MD
Professor of Medicine
Vatche and Tamar Manoukian Division of Digestive Diseases
David Geffen School of Medicine at UCLA
Los Angeles, California
The goal of this activity is to improve rural clinicians’ competence in effectively communicating with patients about sensitive GI concerns; diagnosing IBS-C, IBS-D, and CIC; and developing evidence-based treatment regimens to alleviate symptoms.
This program is intended for physicians, physician assistants, nurse practitioners, nurses, and other healthcare providers who care for patients with IBS or CIC.
- Utilize Rome criteria to diagnose IBS-D and IBS-C, and distinguish IBS-C from CIC
- Consider evidence-based therapies for patients with IBS who have not responded to conventional dietary and pharmacologic interventions
American Gastroenterological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Continuing Medical Education
American Gastroenterological Association designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Disclosure of Conflicts of Interest
The American Gastroenterological Association requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the AGA policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.